NO995564D0 - Method and construction for cell migration inhibition - Google Patents

Method and construction for cell migration inhibition

Info

Publication number
NO995564D0
NO995564D0 NO995564A NO995564A NO995564D0 NO 995564 D0 NO995564 D0 NO 995564D0 NO 995564 A NO995564 A NO 995564A NO 995564 A NO995564 A NO 995564A NO 995564 D0 NO995564 D0 NO 995564D0
Authority
NO
Norway
Prior art keywords
construction
cell migration
migration inhibition
inhibition
cell
Prior art date
Application number
NO995564A
Other languages
Norwegian (no)
Other versions
NO995564L (en
Inventor
Paulus Hubertus Andreas Quax
Johan Hendrikus Verheijen
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Publication of NO995564D0 publication Critical patent/NO995564D0/en
Publication of NO995564L publication Critical patent/NO995564L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO995564A 1997-05-12 1999-11-12 Method and construction for cell migration inhibition NO995564L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201423 1997-05-12
PCT/NL1998/000259 WO1998051788A2 (en) 1997-05-12 1998-05-11 Method and construct for inhibition of cell migration

Publications (2)

Publication Number Publication Date
NO995564D0 true NO995564D0 (en) 1999-11-12
NO995564L NO995564L (en) 2000-01-11

Family

ID=8228315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995564A NO995564L (en) 1997-05-12 1999-11-12 Method and construction for cell migration inhibition

Country Status (7)

Country Link
EP (1) EP0981606A2 (en)
JP (1) JP2001525669A (en)
AU (1) AU7553698A (en)
CA (1) CA2289117A1 (en)
NO (1) NO995564L (en)
NZ (1) NZ500656A (en)
WO (1) WO1998051788A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055365A1 (en) 1998-04-30 1999-11-04 Cornell Research Foundation, Inc. Adenoviral vectors with tandem fiber proteins
US6455314B1 (en) 1998-09-11 2002-09-24 Genvec, Inc. Alternatively targeted adenovirus
DE10020125A1 (en) 2000-04-18 2001-10-25 Friedrich Schiller Uni Jena Bu Agent for stimulating bone regrowth, useful as insert after surgery for bone cancer, comprises single sequence expressing a fusion of growth factor and protease inhibitor
EP1903113A1 (en) * 2000-12-18 2008-03-26 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
AU2002241661B2 (en) * 2000-12-18 2007-05-31 Arriva Pharmaceuticals, Inc Multifunctional protease inhibitors and their use in treatment of disease
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
ATE467680T1 (en) 2001-10-11 2010-05-15 Merck Sharp & Dohme HEPATITIS C VIRUS VACCINE
DE60236364D1 (en) * 2001-10-11 2010-06-24 Angeletti P Ist Richerche Bio Hepatitis-c-virus-impfstoff

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318554B2 (en) * 1987-05-21 2005-01-12 Micromet AG Targeted multifunctional proteins
US5504001A (en) * 1987-11-25 1996-04-02 Zymogenetics, Inc. Hybrid plasminogen activator
DE69025211T2 (en) * 1989-02-17 1996-09-19 Merck & Co Inc Protein anti-cancer drug
JP2877509B2 (en) * 1989-05-19 1999-03-31 アムジエン・インコーポレーテツド Metalloproteinase inhibitors
ES2060134T3 (en) * 1989-05-26 1994-11-16 Univ Washington METALOPROTEASE TISSUE INHIBITOR (TIMP-2).
AU657087B2 (en) * 1989-12-22 1995-03-02 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region
ATE212059T1 (en) * 1990-02-15 2002-02-15 METHODS FOR IDENTIFYING HETEROFUNCTIONAL FUSION PROTEINS
GB2246779B (en) * 1990-08-03 1994-08-17 Delta Biotechnology Ltd Tumour-associated protease inhibitors targeted to tumour cells
JPH09504174A (en) * 1993-10-29 1997-04-28 インサイト ファーマシューティカルズ，インク． Chimeric protein containing protease nexin 1 mutant
WO1995013091A1 (en) * 1993-11-12 1995-05-18 International Technology Management Associates, Ltd. Methods of repairing connective tissues
US5550213A (en) * 1993-12-27 1996-08-27 Rutgers, The State University Of New Jersey Inhibitors of urokinase plasminogen activator
DE69533472T2 (en) * 1994-01-11 2006-01-12 Dyax Corp., Cambridge KALLIKER INHIBITING "KUNITZ DOMAIN" PROTEINS AND DERIVATIVES THEREOF
WO1995028955A1 (en) * 1994-04-22 1995-11-02 Gliemann Joergen PEPTIDES BINDING TO THE α2-MACROGLOBULIN RECEPTOR/LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN
US5712149A (en) * 1995-02-03 1998-01-27 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals
US5843724A (en) * 1995-04-27 1998-12-01 Rutgers University Chimeric nucleic acids and proteins for inhibiting HIV-1 expression
US5726050A (en) * 1995-06-20 1998-03-10 Massachusetts Institute Of Technology Z-DNA binding protein and applications
AU1210797A (en) * 1996-01-08 1997-08-01 Nissin Food Products Co., Ltd. Cancerous metastasis inhibitor

Also Published As

Publication number Publication date
JP2001525669A (en) 2001-12-11
EP0981606A2 (en) 2000-03-01
WO1998051788A3 (en) 1999-05-20
NZ500656A (en) 2001-11-30
NO995564L (en) 2000-01-11
WO1998051788A2 (en) 1998-11-19
CA2289117A1 (en) 1998-11-19
AU7553698A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
FI102426B1 (en) Method for implementing memory
FI102424B1 (en) Method for implementing memory
DK0811006T3 (en) Benzopyran-containing compounds and methods for their use
DE69841090D1 (en) Charge control method and apparatus
FI962055A (en) Battery extension and related method
NO990110D0 (en) Prefabricated shower module and method of shower design
NO973464D0 (en) Extension tube - scraper plug and method
NO20003096L (en) Compositions and Methods for Treating ADD
IS5158A (en) Genetic separators and methods
NO983366L (en) Method and apparatus for determining the path of boreholes
FI102425B1 (en) Method for implementing memory
DE69838897D1 (en) Recording method and apparatus
FI970820A (en) Icebreaking method and icebreaker
FI991156A0 (en) Drilling system and method
NO984563D0 (en) Method and Blend for Corrosion Inhibition
EE9900598A (en) Method and system of payment
NO20001732L (en) Water purification device and method
NO983082D0 (en) Method and device for energy development
NO995564L (en) Method and construction for cell migration inhibition
DE69828227D1 (en) recording method
NO991577D0 (en) Borehole testing method and system
ID18300A (en) METHOD OF PENEMPERAN
NO993506L (en) Pipe foundations and methods for making them
NO995159L (en) Method and apparatus for making asphalt
NO20001011D0 (en) Power measurement system and method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application